Summary
- Current Price
- As of today, IPSC price is $1.31, down -1.14% in the most recent trading session on
- Current Price All-Time High
- IPSC price is currently -96.03% below its historical high of $32.90 set on
- Market Cap
- IPSC current market cap is $236M, up +388.54% over the past 365 days
- Revenue
- IPSC current annual revenue is $109.16M, up +1556.76% year-over-year
- Next Earnings
- The next earnings release for IPSC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Century Therapeutics, Inc. |
| Ticker | NASDAQ: IPSC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | centurytx.com |
| Employees | 140 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.31 | ||
| Price, 1D Change | -1.14% | |
| $236M | ||
| - | ||
| - | ||
| 2.00 | ||
| $109.16M | ||
| Revenue, 1Y Change | +1,556.76% | |
| -$0.11 | ||
| EPS, 1Y Change | +93.12% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.11 | ||
| EPS Estimate | -$0.45 | N/A |
| EPS Est. Change | -306.50% | N/A |
| $109.16M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $1.31 | ||
| Price Target | $4.50 | - |
| Price Tgt. Change | +244.83% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.63 | -$1.61 | +0.97% | |
| -$0.13 | -$0.11 | +14.85% | |
| -$0.45 | N/A | -306.50% | |
| -$0.45 | N/A | -308.76% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.35M | $6.59M | +96.87% | |
| $109.17M | $109.16M | -0.01% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +133.45% | ||
| -20.91% | ||
| +388.54% | ||
| +140.64% | ||
| +1,556.76% | ||
| +1,999.71% | ||
| +93.12% | ||
| +95.12% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.31 | ||
| $2.08 | ||
| $1.93 | ||
| $1.88 | ||
| $1.90 | ||
| -$0.15 | ||
| 2.00 | ||
| $0.12 | ||
| 21.04 | ||
| 64.09% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $109.16M | ||
| -$0.11 | ||
| $96.06M | ||
| 88.00% | ||
| -$15.04M | ||
| -13.78% | ||
| -$9.58M | ||
| -8.78% | ||
| -$1.94M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.27 | ||
| 5.97 | ||
| 5.97 | ||
| - | ||
| - | ||
| -1.96 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.02 | ||
| -1.63 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $158.94M | ||
| $117.91M | ||
| $223.70M | ||
| $120.77M | ||
| $64.77M | ||
| $20.23M | ||
| $43.57M | ||
| $3.32M | ||
| $4.77M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $118.74M | ||
| $111.10M | ||
| $13.10M | ||
| $0.00 | ||
| $13.10M | ||
| $0.00 | ||
| -$68.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$103.88M | ||
| $107.50M | ||
| $173.00K | ||
| $848.00K | ||
| -$104.72M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Mizuho | ||
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| Leerink Partners | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Chardan Capital | → | |
| Guggenheim | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with IPSC
FAQ
- What is the ticker symbol for Century Therapeutics, Inc.?
- The ticker symbol for Century Therapeutics, Inc. is NASDAQ:IPSC
- Does Century Therapeutics, Inc. pay dividends?
- No, Century Therapeutics, Inc. does not pay dividends
- What sector is Century Therapeutics, Inc. in?
- Century Therapeutics, Inc. is in the Healthcare sector
- What industry is Century Therapeutics, Inc. in?
- Century Therapeutics, Inc. is in the Biotechnology industry
- What country is Century Therapeutics, Inc. based in?
- Century Therapeutics, Inc. is headquartered in United States
- When did Century Therapeutics, Inc. go public?
- Century Therapeutics, Inc. initial public offering (IPO) was on June 18, 2021
- Is Century Therapeutics, Inc. in the S&P 500?
- No, Century Therapeutics, Inc. is not included in the S&P 500 index
- Is Century Therapeutics, Inc. in the NASDAQ 100?
- No, Century Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Century Therapeutics, Inc. in the Dow Jones?
- No, Century Therapeutics, Inc. is not included in the Dow Jones index
- When was Century Therapeutics, Inc. last earnings report?
- Century Therapeutics, Inc.'s most recent earnings report was on August 12, 2026
- When does Century Therapeutics, Inc. report earnings?
- The next expected earnings date for Century Therapeutics, Inc. is November 12, 2026
Data Sources & References
- IPSC Official Website www.centurytx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1850119/000110465926026759/0001104659-26-026759-index.htm
- IPSC Profile on Yahoo Finance finance.yahoo.com/quote/IPSC
- IPSC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ipsc